Pharmacy Practice & Operations
Health-System Pharmacy
Pharmacy practice and leadership in hospitals and integrated health systems.
Health-System Pharmacy at a glance
- About this topic
- Pharmacy practice and leadership in hospitals and integrated health systems.
- In the Knowledge Hub
- Content on this topic is in development.
- Live intelligence
- Tracked from official sources on 503B outsourcing facilities, Drug shortages and USP compounding standards.
- Latest official record
- Medline Updates Customers and Patients on Repair and Replace Program for Recall of Medline Brand Beds, Rails, Mattresses and Accessories (opens the source in a new tab) (U.S. Food and Drug Administration, Nov 13, 2026)
General professional education. Not accredited continuing education, and not clinical, legal or financial advice.
Articles and resources
Content on this topic is in development
We publish carefully and only when content is genuinely useful. Get updates when new insights are published, or propose a contribution.
What is changing in this area right now?
Topic intelligenceOfficial records and reference tools from NPHLA Intelligence on the subjects closest to this topic.
- Medline Updates Customers and Patients on Repair and Replace Program for Recall of Medline Brand Beds, Rails, Mattresses and Accessories (opens the source in a new tab)
On October 14, 2026, Medline initiated a product recall, market exit and discontinuation of all Medline Brand beds, rails, mattresses, and accessories (e.g., pendants and motor boxes) due to a potential fire hazard and entrapment risk, which may result in patient injury or dea…
- Eugia US LLC (f/k/a Auro Medics Pharma LLC) Issues Voluntary Nationwide Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) Due to Presence of Particulate Matter (opens the source in a new tab)
FOR IMMEDIATE RELEASE –November 06,2026 – East Windsor, New Jersey, Eugia US LLC (f/k/a Auro Medics Pharma LLC) is voluntarily recalling lot number 3VM26026A of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) to the hospital/healthcare facility/us…
- New trial registered: ERCG vs Intensive Lifestyle Intervention for Weight Regain After GLP-1 RA Discontinuation (opens the source in a new tab)
Not applicable, Affiliated Hospital to Academy of Military Medical Sciences. Conditions: Obesity & Overweight. Interventions: Endoscopic Radial Compression Gastroplasty (ERCG); Intensive Lifestyle Intervention (ILI). Investigational: trial-stage therapies are not approved for …
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02). Company: Hikma Pharmaceuticals USA, Inc.
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03). Company: Hikma Pharmaceuticals USA, Inc.
- Weight Maintenance Following Discontinuation of Semaglutide in an Adolescent with Antipsychotic-Associated Weight Gain: A Case Report (opens the source in a new tab)